These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18021749)

  • 1. Evaluation of 4,5,6,7-tetrahalogeno-1H-isoindole-1,3(2H)-diones as inhibitors of human protein kinase CK2.
    Golub AG; Yakovenko OY; Prykhod'ko AO; Lukashov SS; Bdzhola VG; Yarmoluk SM
    Biochim Biophys Acta; 2008 Jan; 1784(1):143-9. PubMed ID: 18021749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
    Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
    Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases.
    Cozza G; Sarno S; Ruzzene M; Girardi C; Orzeszko A; Kazimierczuk Z; Zagotto G; Bonaiuto E; Di Paolo ML; Pinna LA
    Biochim Biophys Acta; 2013 Jul; 1834(7):1402-9. PubMed ID: 23360763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight.
    Lolli G; Cozza G; Mazzorana M; Tibaldi E; Cesaro L; Donella-Deana A; Meggio F; Venerando A; Franchin C; Sarno S; Battistutta R; Pinna LA
    Biochemistry; 2012 Aug; 51(31):6097-107. PubMed ID: 22794353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2.
    Golub AG; Bdzhola VG; Briukhovetska NV; Balanda AO; Kukharenko OP; Kotey IM; Ostrynska OV; Yarmoluk SM
    Eur J Med Chem; 2011 Mar; 46(3):870-6. PubMed ID: 21276643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.
    Raaf J; Brunstein E; Issinger OG; Niefind K
    Chem Biol; 2008 Feb; 15(2):111-7. PubMed ID: 18291315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dark side of protein kinase CK2 inhibition.
    Cozza G; Meggio F; Moro S
    Curr Med Chem; 2011; 18(19):2867-84. PubMed ID: 21651492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L; Turowec JP; Bretner M; Litchfield DW
    Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors.
    Hundsdörfer C; Hemmerling HJ; Götz C; Totzke F; Bednarski P; Le Borgne M; Jose J
    Bioorg Med Chem; 2012 Apr; 20(7):2282-9. PubMed ID: 22377675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and characterization of synthetic 4'-hydroxyflavones-New CK2 inhibitors from flavone family.
    Golub AG; Bdzhola VG; Ostrynska OV; Kyshenia IV; Sapelkin VM; Prykhod'ko AO; Kukharenko OP; Yarmoluk SM
    Bioorg Med Chem; 2013 Nov; 21(21):6681-9. PubMed ID: 24011954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New protein kinase CK2 inhibitors: jumping out of the catalytic box.
    Prudent R; Cochet C
    Chem Biol; 2009 Feb; 16(2):112-20. PubMed ID: 19246001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selectivity of inhibitors of protein kinase CK2: an update.
    Pagano MA; Bain J; Kazimierczuk Z; Sarno S; Ruzzene M; Di Maira G; Elliott M; Orzeszko A; Cozza G; Meggio F; Pinna LA
    Biochem J; 2008 Nov; 415(3):353-65. PubMed ID: 18588507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-4-ones as a new class of CK2 inhibitors.
    Protopopov MV; Ostrynska OV; Starosyla SA; Vodolazhenko MA; Sirko SM; Gorobets NY; Bdzhola V; Desenko SM; Yarmoluk SM
    Mol Divers; 2018 Nov; 22(4):991-998. PubMed ID: 29845490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of 3-quinoline carboxylic acids as new inhibitors of protein kinase CK2.
    Syniugin AR; Ostrynska OV; Chekanov MO; Volynets GP; Starosyla SA; Bdzhola VG; Yarmoluk SM
    J Enzyme Inhib Med Chem; 2016; 31(sup4):160-169. PubMed ID: 27590574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.
    Leung KK; Shilton BH
    Biochemistry; 2015 Jan; 54(1):47-59. PubMed ID: 25379648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
    Chojnacki K; Wińska P; Wielechowska M; Łukowska-Chojnacka E; Tölzer C; Niefind K; Bretner M
    Bioorg Chem; 2018 Oct; 80():266-275. PubMed ID: 29966873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and exploitation of CK2 inhibitors.
    Sarno S; Ruzzene M; Frascella P; Pagano MA; Meggio F; Zambon A; Mazzorana M; Di Maira G; Lucchini V; Pinna LA
    Mol Cell Biochem; 2005 Jun; 274(1-2):69-76. PubMed ID: 16335530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase CK2 inhibition: an update.
    Cozza G; Pinna LA; Moro S
    Curr Med Chem; 2013; 20(5):671-93. PubMed ID: 23210774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, in vitro protoporphyrinogen oxidase inhibition, and herbicidal activity of N-(benzothiazol-5-yl)hexahydro-1H-isoindole-1,3-diones and N-(benzothiazol-5-yl)hexahydro-1H-isoindol-1-ones.
    Wu QY; Jiang LL; Zuo Y; Wang ZF; Xi Z; Yang GF
    Chem Biol Drug Des; 2014 Oct; 84(4):431-42. PubMed ID: 24803371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of dual kinase inhibitors of CK2 and GSK3β: combined qualitative and quantitative pharmacophore modeling approach.
    Pardhi T; Vasu K
    J Biomol Struct Dyn; 2018 Jan; 36(1):177-194. PubMed ID: 27960601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.